Trial Details

COMPLETED
Basic Information
Clinical ID c1699
Identifier NCT02048618
Trial Title Efficacy and Safety of GLPG0634 in Subjects With Active Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Crohn's Disease
Interventions DRUG: GLPG0634|DRUG: Placebo
Participant Information
Sponsor Galapagos NV
City Brussels
Country/Region Belgium
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2025-02-14
Primary Completion Date 2025-11-15
Completion Date 2025-02-16